102 related articles for article (PubMed ID: 11712467)
21. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort.
Kiewert C; Buchholzer ML; Hartmann J; Chatterjee SS; Klein J
Neurosci Lett; 2004 Jul; 364(3):195-8. PubMed ID: 15196674
[TBL] [Abstract][Full Text] [Related]
22. Further degradation product of hyperforin from Hypericum perforatum (St John's Wort).
Vajs V; Vugdelija S; Trifunović S; Karadzić I; Juranić N; Macura S; Milosavljević S
Fitoterapia; 2003 Jul; 74(5):439-44. PubMed ID: 12837358
[TBL] [Abstract][Full Text] [Related]
23. [Dangerous interaction of St. John's wort with chemotherapy?].
Schmitt J
Pharm Unserer Zeit; 2003; 32(1):8. PubMed ID: 12577753
[No Abstract] [Full Text] [Related]
24. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials.
Trautmann-Sponsel RD; Dienel A
J Affect Disord; 2004 Oct; 82(2):303-7. PubMed ID: 15488262
[TBL] [Abstract][Full Text] [Related]
25. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
Muruganandam AV; Bhattacharya SK; Ghosal S
Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
[TBL] [Abstract][Full Text] [Related]
26. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
Weber CC; Kressmann S; Fricker G; Müller WE
Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
[TBL] [Abstract][Full Text] [Related]
27. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse.
Cantoni L; Rozio M; Mangolini A; Hauri L; Caccia S
Toxicol Sci; 2003 Sep; 75(1):25-30. PubMed ID: 12857935
[TBL] [Abstract][Full Text] [Related]
28. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
29. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
30. A current review of the antimicrobial activity of Hypericum perforatum L.
Reichling J; Weseler A; Saller R
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S116-8. PubMed ID: 11518059
[TBL] [Abstract][Full Text] [Related]
31. Hypericum perforatum, a source of neuroactive lead structures.
Verotta L
Curr Top Med Chem; 2003; 3(2):187-201. PubMed ID: 12570773
[TBL] [Abstract][Full Text] [Related]
32. Effects of two different extracts of St. John's wort and some of their constituents on cytochrome P450 activities in rat liver microsomes.
Nöldner M; Chatterjee S
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S108-10. PubMed ID: 11518056
[TBL] [Abstract][Full Text] [Related]
33. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
Murch SJ; Rupasinghe HP; Saxena PK
Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339
[TBL] [Abstract][Full Text] [Related]
34. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
Butterweck V; Winterhoff H; Herkenham M
Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
[TBL] [Abstract][Full Text] [Related]
35. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
[TBL] [Abstract][Full Text] [Related]
36. Hyperforin: more than an antidepressant bioactive compound?
Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR
Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991
[TBL] [Abstract][Full Text] [Related]
37. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
39. Three new hyperforin analogues from Hypericum perforatum.
Shan MD; Hu LH; Chen ZL
J Nat Prod; 2001 Jan; 64(1):127-30. PubMed ID: 11170687
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
